Two Third Party GMP Audits performed in Germany by API Compliance Institute
The API Compliance Institute recently performed Third Party GMP Audits at two API manufacturing sites in Germany. The Audits were initiated by a group of Qualified Persons and QA Managers from different pharmaceutical companies who are using the respective APIs to manufacture their medicinal products. The initiators as well as the Auditee agreed to share the audit reports with other companies.
The GMP Audits were performed by 2 certified APIC Auditors during 2 days at each manufacturing site. They were conducted according to the rules of the APIC Audit Programme. This GMP Audit Scheme is an internationally recognized auditing programme which was established 10 years ago. It is the idea of the programme to share compliance information between companies.
The following sites were audited:
Site: Excella GmbH
Nürnberger Str. 12
90537 Feucht
and
Site: Boehringer Ingelheim Pharma GmbH & Co. KG
Binger Str. 173
55216 Ingelheim
The API Compliance Institute is responsible for the controlled distribution of the audit report in which the GMP compliance situation at the two API manufacturing sites has been described in detail. More information can be obtained from the following source: Press Release API Compliance Insitute
Related GMP News
02.09.2026Deficiencies in Staffing, Monitoring and Aseptic Techniques – Warning Letter to a European Company
26.08.2026FDA Warning Letter: Inadequate Warehouse Controls and Lot Traceability
19.08.2026Poor Hygiene and Environmental Conditions - FDA Warning Letter
28.07.2026Pre-approval Inspections: FDA introduces New Guidance
22.07.2026Do you know about QPSHARE?